Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.70
-0.35 (-1.03%)
Apr 2, 2026, 1:18 PM CST

Sofiva Genomics Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-9.3618.4311.5342.7856.98
Depreciation & Amortization
41.6141.6241.3442.7941.95
Loss (Gain) From Sale of Assets
0.02---0.02-
Loss (Gain) on Equity Investments
-23.3-25.35-23.67-41.9-31.05
Stock-Based Compensation
-0.01-0.731.072.682.87
Provision & Write-off of Bad Debts
0.01-0-0.49-0.14
Other Operating Activities
1.398.46-3.92-2.991.58
Change in Accounts Receivable
2.945.6-2.230.94-12.39
Change in Inventory
11.55-4.6115.29-15.528.55
Change in Accounts Payable
0.17-9.25-18.89-3.647.72
Change in Unearned Revenue
-0.591-1.34-0.58-0.56
Change in Other Net Operating Assets
-9.07-0.54.5-6.924.56
Operating Cash Flow
15.3634.6923.717.1480.07
Operating Cash Flow Growth
-55.73%46.38%38.30%-78.60%31.65%
Capital Expenditures
-1.16-16.92-21.01-33.53-8.16
Sale of Property, Plant & Equipment
0.04--0.1-
Sale (Purchase) of Intangibles
-7-7.2-3.55-2.17-4.49
Investment in Securities
-9.137.93-20.95-
Other Investing Activities
-6.334.336.653.072.62
Investing Cash Flow
-14.44-10.66-9.99-53.48-10.03
Long-Term Debt Repaid
-15.25-15.81-14.74-15.75-15.54
Total Debt Repaid
-15.25-15.81-14.74-15.75-15.54
Net Debt Issued (Repaid)
-15.25-15.81-14.74-15.75-15.54
Issuance of Common Stock
-12.07--1.12
Common Dividends Paid
-6.48-4.27-21.36-42.73-29.77
Other Financing Activities
-0.55-0.55-0.57-0.18-0
Financing Cash Flow
-22.28-8.57-36.67-58.65-44.19
Foreign Exchange Rate Adjustments
-0.11-0.19-0.05-0.180.29
Net Cash Flow
-21.4715.27-23.01-95.1826.14
Free Cash Flow
14.217.772.69-16.471.91
Free Cash Flow Growth
-20.11%560.18%--58.55%
Free Cash Flow Margin
3.68%3.92%0.58%-3.31%14.14%
Free Cash Flow Per Share
0.650.820.13-0.773.38
Cash Interest Paid
0.81.071.241.441.69
Cash Income Tax Paid
-0.32-3.231.347.615.19
Levered Free Cash Flow
16.910.122.66-20.4163.61
Unlevered Free Cash Flow
17.4310.813.47-19.4864.7
Change in Working Capital
5-7.75-2.66-25.727.88
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.